Setting Treatment Goals and Managing Expectations in CIDP

This episode, titled "Setting Treatment Goals and Managing Expectations in CIDP," features panelists examining how treatment goals evolve across the CIDP disease journey and how clinicians can better align patient expectations with realistic outcomes. For newly diagnosed patients, panelists emphasize the importance of explaining that improvement is typically gradual, that distal muscle recovery may lag behind proximal recovery, and that some residual deficits from axonal degeneration may be permanent. Stabilization of disease — halting progressive decline — is framed as an important early treatment milestone before measurable improvement begins, as remyelination and axonal regeneration can take months to years. The role of rehabilitation is highlighted as an essential complement to immunotherapy, particularly to address deconditioning, fatigue, and endurance limitations that persist even as strength improves.

For patients on chronic immunotherapy who have reached stability, treatment goals shift toward maintaining function while minimizing therapy burden. Panelists describe periodically extending infusion intervals or reducing doses to assess underlying disease activity and determine whether remission has been achieved, acknowledging patient reluctance to taper after prior relapse experiences.

The discussion then addresses the common misalignment between patient and clinician expectations, identifying two key areas of disconnect: the slow timing of response, likened to putting a cruise liner in reverse, and the depth of recovery, given that only a small minority of patients return to full neurological normalcy. Panelists advocate for setting conservative expectations early so that any functional gains feel meaningful to patients. The distinction between anatomical impairment and immunologic disease activity is highlighted as another source of confusion, with panelists noting that residual deficits can persist even when immune activity is well controlled, reinforcing the ongoing need for treatment and objective monitoring tools such as validated disability scales to demonstrate incremental progress over time.

In the next episode, "Shared Decision-Making and Patient-Centered Care in CIDP," panelists will discuss their approaches to shared decision-making when initiating or adjusting treatment in CIDP, highlighting the importance of transparent communication about treatment options, realistic expectation-setting, and empowering patients through education and accessible care to support adherence and informed treatment choices.